ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (Intranasal (IN)…
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better…